Mar 18, 2024 4:05pm EDT Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Read Release
Feb 22, 2024 8:00am EST Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds Read Release
Feb 21, 2024 8:52am EST Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract Read Release
Feb 16, 2024 4:15pm EST Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders Read Release
Jan 30, 2024 8:00am EST Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation Read Release
Dec 18, 2023 10:10pm EST Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering Read Release
Nov 13, 2023 4:05pm EST Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update Read Release
Nov 10, 2023 8:00am EST Motus GI Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu® EVS Gastro Read Release